GET THE APP

Photophobia and Migraine Outcome during Treatment with Galca | 100768

神经病学与神经生理学杂志

ISSN - 2155-9562

抽象的

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Catherine Lapp

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

免责声明: 该摘要是使用人工智能工具翻译的,尚未经过审查或验证。